GlassScriptPhysician profile
Marc H Blasser
NPI 1437245875
$4,020.79
in general payments reported to CMS, 2019-2025
34 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $229 · 2021: $665 · 2022: $578 · 2023: $1,063 · 2024: $608 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,696 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,695.58 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $640.24 | 2019-2023 | Xtandi, Myrbetriq |
| Coloplast Corp | $377.48 | 2019-2024 | Porges Coloplast, Titan |
| Pfizer INC. | $373.10 | 2019-2024 | |
| Boston Scientific Corporation | $347.02 | 2019-2024 | Ams 700, Ams 700 Cxr Rte Kit |
| Endo Pharmaceuticals INC. | $271.96 | 2019-2024 | Xiaflex |
| Teleflex LLC | $270.04 | 2022-2024 | Urolift |
| Abbvie INC. | $207.19 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $132.66 | 2019-2024 | Adstiladrin |
| Calyxo, INC. | $124.05 | 2025 | Cvac Aspiration System |
| Ambu INC. | $122.35 | 2024 | |
| Janssen Biotech, INC. | $121.88 | 2019-2022 | |
| Axonics, INC. | $114.75 | 2023 | Axonics |
| Cook Medical LLC | $101.41 | 2024 | Cook |
| Sumitomo Pharma America, INC. | $92.39 | 2023-2024 | Orgovyx, Gemtesa |
| Novartis Pharmaceuticals Corporation | $89.98 | 2022-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $79.61 | 2019-2020 | |
| Rochester Medical Corporation | $76.15 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.94 | 2021-2022 | |
| Tolmar, INC. | $43.59 | 2023 | |
| 180 Medical, INC. | $43.12 | 2021 | |
| Allergan, INC. | $39.53 | 2019-2021 | |
| Davol INC. | $37.07 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $35.12 | 2022 | |
| Acerus Pharmaceuticals Corporation | $29.46 | 2021 | |
| Alnylam Pharmaceuticals INC. | $29.35 | 2024 | Oxlumo |
| Myovant Sciences INC. | $25.05 | 2022 | |
| Antares Pharma, INC. | $23.17 | 2019 | |
| Neotract INC. | $20.85 | 2019 | |
| Urovant Sciences INC | $18.76 | 2022 | |
| Sagent Pharmaceuticals | $17.92 | 2019 | |
| Olympus America INC. | $17.74 | 2022 | |
| Urogen Pharma, INC. | $15.27 | 2023 | Jelmyto |
| C. R. Bard, INC. & Subsidiaries | $14.58 | 2019 | |
| Clarus Therapeutics INC. | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Blasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.